The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10148 malaria professionals are enjoying the free benefits of MalariaWorld today

artemether-lumefantrine

Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria

June 8, 2016 - 15:59 -- Open Access
Author(s): 
Sowunmi A, Akano K, Ayede A, Ntadom G, Aderoyeje T, Adewoye E, Fatunmbi B
Reference: 
BMC Infectious Diseases 2016, 16:240 (1 June 2016)

This was an open label study with the main objectives of evaluating the clinical features, the risk factors for, the temporal changes in haematocrit and the outcomes of a LAA in malarious children treated with artesunate-amodiaquine (AA), artemether-lumefantrine (AL) or dihydroartemisinin-piperaquine (DHP). 

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial

March 10, 2016 - 14:14 -- Open Access
Author(s): 
Gonçalves B, Tiono A, Bousema T, et al.
Reference: 
BMC Medicine 2016, 14 :40 (8 March 2016)

We observed similar gametocyte clearance rates after 0.25 and 0.40 mg/kg primaquine doses. Infectivity to mosquitoes after AL was very low and absent in primaquine arms.

Maximizing antimalarial efficacy and the importance of dosing strategies

May 12, 2015 - 15:57 -- Open Access
Author(s): 
James G Beeson, Philippe Boeuf and Freya JI Fowkes
Reference: 
BMC Medicine 2015, 13:110

In the most recent study, an analysis of clinical trials of artesunate-amodiaquine, widely used among children in Africa, revealed a superior efficacy for fixed-dose combination tablets compared to loose non-fixed dose combinations.

Exposure to artemether-lumefantrine (Coartem®) in first trimester pregnancy in an observational study in Zambia

March 9, 2015 - 14:58 -- Open Access
Author(s): 
Christine Manyando, Eric M Njunju, Mailis Virtanen, Kamal Hamed, Melba Gomes, Jean-Pierre Van geertruyden
Reference: 
Malaria Journal 2015, 14:77 (14 February 2015)

This report assessed the longitudinal safety outcomes of the pregnant women inadvertently exposed during the first trimester.

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens

March 3, 2015 - 14:25 -- Open Access
Author(s): 
James Kapisi, Victor Bigira, Tamara Clark, Stephen Kinara, Florence Mwangwa, Jane Achan, Moses Kamya, Seyi Soremekun, Grant Dorsey
Reference: 
Malaria Journal 2015, 14:53 (5 February 2015)

 In the setting of chemoprevention, treatment of uncomplicated malaria with AL was safe and efficacious, with moderate protection against recurrent malaria among children assigned monthly DP.

Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia

November 25, 2014 - 17:06 -- Open Access
Author(s): 
Busiku Hamainza, Freddie Masaninga, Hawela Moonga, Mulenga Mwenda, Pascalina Chanda-kapata, Victor Chalwe, Emmanuel Chanda, Mulakwa Kamuliwo, Olusegun Ayorinde Babaniyi
Reference: 
Malaria Journal 2014, 13:430 (17 November 2014)

This study assessed the therapeutic efficacy and safety of artemether-lumefantrine (AL)(Coartem(R)) for the treatment of uncomplicated Plasmodium falciparum malaria in two sentinel high malaria transmission districts in the Eastern Province of Zambia in persons aged six months and above, excluding women aged 12 to 18 years.

Country: 

Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania

September 30, 2014 - 19:13 -- Open Access
Author(s): 
Shayo A, Mandara CI, Shahada F, Buza J, Lemnge MM, Ishengoma DS
Reference: 
Malaria Journal 2014, 13 :376 (20 September 2014)

This study showed that AL was safe, well-tolerated and efficacious for treatment of uncomplicated falciparum malaria.

A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria

September 25, 2014 - 12:07 -- Open Access
Author(s): 
Adjei GO, Goka BQ, Enweronu-Laryea CC, Rodrigues OP, Renner L, Sulley AM, Alifrangis M, Khalil I, Kurtzhals JA
Reference: 
Malaria Journal 2014, 13 :369 (19 September 2014)

Children with SCD and acute uncomplicated malaria (n = 60) were randomized to treatment with artesunate-amodiaquine (AA), or artemether-lumefantrine (AL). A comparison group of non-SCD children (HbAA genotype; n = 59) with uncomplicated malaria were also randomized to treatment with AA or AL.

In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique

August 19, 2014 - 14:04 -- Open Access
Author(s): 
Nhama A, Bassat Q, Macete E, et al.
Reference: 
Malaria Journal 2014, 13 :309 (10 August 2014)

This study confirms that both AL and ASAQ remain highly efficacious and well tolerated for the treatment of uncomplicated malaria in Mozambican children.

Country: 
Medical Treatment: 

Malaria diagnostic capacity in health facilities in Ethiopia

August 15, 2014 - 16:21 -- Open Access
Author(s): 
Abreha T, Alemayehu B, Teka H, et al.
Reference: 
Malaria Journal 2014, 13 :292 (29 July 2014)

A descriptive cross-sectional study was conducted from February to April 2011 in 122 health facilities, where health professionals were interviewed using a pre-tested, standardized assessment tool and facilities’ laboratory practices were assessed by direct observation.

Pages

Subscribe to RSS - artemether-lumefantrine